AstraZeneca - the pharmaceutical collaborating with Oxford University on developing a coronavirus vaccine - has committed to running an extra trial.
It follows allegations that the British–Swedish multinational was cherry-picking data during its initial tests, as Benji Hyer explains from London.
IN: The company announced
OUT: SOC
DUR: 40 secs
http://www.fsnradionews.com/feeds/1126vaccine-bh-generic.mp3